Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.
Press releases published on July 18, 2025

PGA TOUR Cognizant Classic Awards Grant to FMU to Launch Golf Club in Spring 2026
PGA TOUR’s Cognizant Classic Awards Grant to Florida Memorial University to Launch Student Golf Club and Expand Access to the Sport in Spring 2026 MIAMI GARDENS, FL, UNITED STATES, July 18, 2025 /EINPresswire.com/ -- Florida Memorial University (FMU), …

MyBTCX.com Adds Google Pay for Instant Global Crypto Purchases
Android …

Moneyweb launches ‘Mandates and Megaphones’ - a bold new G20-focused podcast hosted by Jeremy Maggs
Moneyweb launches Mandates and Megaphones, a weekly G20-focused podcast hosted by Jeremy Maggs ahead of SA’s first-ever G20 Summit in November. JOHANNESBURG, SOUTH AFRICA, July 18, 2025 /EINPresswire.com/ -- As South Africa prepares to host the G20 …

Aerial Works Achieves Triple ISO Certification: A New Standard in Drone Security for Mining and Industrial Sectors
A New Standard in Drone Security for Mining and Industrial Sectors JOHANNESBURG, GAUTENG, SOUTH AFRICA, July 18, 2025 /EINPresswire.com/ -- Aerial Works, a South African leader in drone-powered security operations, has officially achieved ISO …

SAPU Bioscience 重點報導經同業-評審的出版刊物,指出 TGFB2 與年輕胰臟癌患者的存活期息息相關
數據支持進一步評估試驗性的反義寡核苷酸 OT-101 (trabedersen) 作為胰臟導管腺癌中 TGFB2- 標靶治療方案的效果。 聖地亞哥,加州, July 19, 2025 (GLOBE NEWSWIRE) -- GMP Biotechnology Limited (GMP Bio) 的全資附屬公司 Sapu Biosciences, LLC (Sapu),與開發針對癌症及罕見疾病的 RNA -標靶和小-分子療法的臨床-階段生物製藥公司 Oncotelic Therapeutics, Inc. ( …

SAPU Bioscience 重点介绍一篇经同行-评审的论文,揭示 TGFB2 与较年轻胰腺癌患者生存期之间的关联
现有数据支持进一步评估在研反义药物 OT-101(又名 trabedersen)作为靶向 TGFB2 -的治疗策略,用于胰腺导管腺癌的疗效。 圣地亚哥,加利福尼亚州, July 19, 2025 (GLOBE NEWSWIRE) -- Sapu Biosciences, LLC (Sapu),是 GMP Biotechnology Limited(简称 GMP Bio)的全资子公司,与临床-阶段生物制药公司 Oncotelic Therapeutics, Inc.(OTCQB: OTLC,简称 …

Vortex Energy Corp. Announces Extension of Marketing Program
VANCOUVER, British Columbia, July 18, 2025 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce, further to its news release on May 30, 2025, that it has further extended its …

Aventis Energy Announces Warrant Expiry Acceleration
VANCOUVER, British Columbia, July 18, 2025 (GLOBE NEWSWIRE) -- Aventis Energy. (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF), announces that the Company has elected to accelerate the expiry date of outstanding common share purchase …

HPQ Silicon Cancels 5,335,000 Stock Options
MONTREAL, July 18, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, announces that its Board of …

HPQ Silicium annule 5 335 000 options
MONTRÉAL, 18 juill. 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique axée sur l’innovation dans le développement de matériaux avancés et de procédés critiques, annonce …

Hudbay to Host Conference Call for Second Quarter 2025 Results
TORONTO, July 18, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) senior management will host a conference call on Wednesday, August 13, 2025 at 11:00 a.m. ET to discuss the Company’s second quarter 2025 results. …

Stallion Uranium Completes Shares for Debt
VANCOUVER, British Columbia, July 18, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce that, further to its news release dated May 22, 2025, the Company has settled …

Generation Bio Announces 1-for-10 Reverse Stock Split
CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that it will implement a 1-for-10 …

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Securing Place in Revitalized Market
NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN ( …

Robex remains on track for first gold at Kiniero in Q4 CY25
Highlights: Construction at Robex’s Kiniero Gold Project, Guinea, remains on schedule and budget - first gold pour on track for Q4 CY25. Project remains LTI free (lost time injury) with 3,666,920 hours worked since January 2023. Phase 1 grade control …

Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics for the treatment of metabolic diseases, today announced …

MEXC Publishes Q2 Report Showing Market Leadership in Listings and Security Reserves
VICTORIA, Seychelles, July 18, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, announced its Q2 2025 performance results, reporting substantial growth across new token listings, user acquisition, ecosystem investments, and platform …

MEXC Launches PUMP Futures Competition for European Users with 20,000 USDT Prize Pool
VICTORIA, Seychelles, July 18, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, today announced the launch of an exclusive PUMP Futures Competition designed specifically for European users. The 8-day competition, running from July …

SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
Data supports further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma. SAN DIEGO, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Sapu Biosciences, LLC (Sapu), a wholly owned …

Successful Commercial Launch of Ryoncil®
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue from sales of Ryoncil® (remestemcel-L-rknd) through the first …